Study links vitamin D to heart disease and early death

By Nathan Gray contact

- Last updated on GMT

Vitamin D to heart disease and early death
Low levels of vitamin D may be associated with a ‘markedly higher’ risk of heart attack and early death, according to new research.

The study – published in Arteriosclerosis, Thrombosis and Vascular Biology – ​investigated the links between vitamin D levels and the incidence of heart disease and mortality in a population-based study of more than 10,000 people in Denmark – in addition to a meta-analysis of 35 other studies.

The group, led by Dr Peter Brøndum-Jacobsen, took plasma 25-hydroxyvitamin D – 25(OH)D –samples from 10 170 women and men from the Danish general population and followed them for an average of 29 years to assess any associations with the incidence of heart disease and premature death. In addition the team performed a meta-analysis 18 studies investigating the risk of ischemic heart disease and 17 studies looking at vitamin D and early death.

"We have now examined the association between a low level of vitamin D and ischemic heart disease and death in the largest study to date,”​ said Peter Brøndum-Jacobsen from the Copenhagen University Hospital, Denmark.

“We observed that low levels of vitamin D compared to optimal levels are linked to 40% higher risk of ischemic heart disease, 64% higher risk of heart attack, 57% higher risk of early death, and to no less than 81% higher risk of death from heart disease,"​ added Brøndum-Jacobsen.

Sunshine vitamin

Vitamin D – often referred to as the sunshine vitamin – deficiency has traditionally been linked with poor bone health and osteoporosis. However research has begun to suggest that the vitamin plays a key role in many immune-related systems. As a result many researchers have begun to investigate possible links between vitamin D deficiency and a host of health conditions – including heart health.

Results from several population studies have indicated, for example, that a low level of this important vitamin may also be linked to a higher risk of ischemic heart disease, while other studies show vitamin D deficiency may increase blood pressure.

Study details

In the new study, Brøndum-Jacobsen and his team compared the lowest 25(OH)D levels of vitamin D (those with less than 15 nanomol vitamin per litre serum) accounting for 5% of the population with those who had adequate levels of vitamin D (defined as more than 50 nanomol vitamin per litre serum) – accounting for approximately 50% of the study population.

The team reported that decreasing 25(OH)D levels were associated with increasing risk of ischemic heart disease, myocardial infarction, and early death.

“Comparing individuals with plasma 25-hydroxyvitamin D levels at the 1st to 4th percentile with individuals with levels at the 50th to 100th percentile, the multivariable adjusted risk was increased by 40% for ischemic heart disease, by 64% for myocardial infarction, by 57% for early death, and by 81% for fatal ischemic heart disease/myocardial infarction,” wrote the authors.

In a further meta-analysis covering a total of 35 studies the team found the risk of ischemic heart disease and early death were increased by 39% and 46% for lowest versus highest quartile of 25(OH)D levels.

"With this type of population study, we are unable to say anything definitive about a possible causal relationship,”​ noted Professor Børge Nordestgaard, of the University of Copenhagen – senior author of the paper. “But we can ascertain that there is a strong statistical correlation between a low level of vitamin D and high risk of heart disease and early death.”

“The explanation may be that a low level of vitamin D directly leads to heart disease and death. However, it is also possible that vitamin deficiency is a marker for poor health generally,"​ he said.

Source:Arteriosclerosis, Thrombosis and Vascular Biolog​y
Published online ahead of print, doi: 10.1161/​ATVBAHA.112.248039
"25-Hydroxyvitamin D Levels and Risk of Ischemic Heart Disease, Myocardial Infarction, and Early Death: Population-Based Study and Meta-Analyses of 18 and 17 Studies"
Authors: Peter Brøndum-Jacobsen, Marianne Benn, Gorm B. Jensen,Børge G. Nordestgaard

Related news

Show more

Related products

show more

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Product Cost Reduction Strategies for the Brand Owner

Product Cost Reduction Strategies for the Brand Owner

Gemini Pharmaceuticals | 11-Sep-2017 | Technical / White Paper

Brand Owners are feeling product price pressure from all corners these days. Consumers are demanding more of the products they buy and want them at a lower...

NattoPharma

12 Reasons MenaQ7® is the Superior Vitamin K2

NattoPharma USA, Inc. | 11-Sep-2017 | Data Sheet

Vitamin K2 as MK-7 supplements are truly changing the face of global health, benefiting old and young alike. We know this because NattoPharma has single-handedly...

Related suppliers

Follow us

Products

View more

Webinars